Murty Santos B, Goodman Jack, Thanoo B C, DeLuca Patrick P
University of Kentucky College of Pharmacy, Lexington, KY, USA.
AAPS PharmSciTech. 2003 Oct 13;4(4):E50. doi: 10.1208/pt040450.
The purpose of this research was to study the chemical reactivity of a somatostatin analogue, octreotide acetate, formulated in microspheres with polymers of varying molecular weight and co-monomer ratio under in vitro testing conditions. Poly(D,L-lactide-co-glycolide) (PLGA) and poly(D,L-lactide) (PLA) microspheres were prepared by a solvent extraction/evaporation method. The microspheres were characterized for drug load, impurity content, and particle size. Further, the microspheres were subjected to in vitro release testing in acetate buffer (pH 4.0) and phosphate buffered saline (PBS) (pH 7.2). In acetate buffer, 3 microsphere batches composed of low molecular weight PLGA 50:50, PLGA 85:15, and PLA polymers (< or =10 kDa) showed 100% release with minimal impurity formation (<10%). The high molecular weight PLGA 50:50 microspheres (28 kDa) displayed only 70% cumulative release in acetate buffer with significant impurity formation (approximately 24%). In PBS (pH 7.4), on the other hand, only 50% release was observed with the same low molecular weight batches (PLGA 50:50, PLGA 85:15, and PLA) with higher percentages of hydrophobic impurity formation (ie, 40%, 26%, and 10%, respectively). In addition, in PBS, the high molecular weight PLGA 50:50 microspheres showed only 20% drug release with ~66% mean impurity content. The chemically modified peptide impurities inside microspheres were structurally confirmed through Fourier transform-mass spectrometry (FT-MS) and liquid chromatography/mass spectrometry (LC-MS/MS) analyses after extraction procedures. The adduct compounds were identified as covalently modified conjugates of octreotide with lactic and glycolic acid monomers within polymeric microspheres. The data suggest that due to steric hindrance factors, polymers with greater lactide content were less amenable to the formation of adduct impurities compared with PLGA 50:50 copolymers.
本研究的目的是在体外测试条件下,研究用不同分子量和共聚单体比例的聚合物制备的生长抑素类似物醋酸奥曲肽微球的化学反应性。采用溶剂萃取/蒸发法制备聚(D,L-丙交酯-共-乙交酯)(PLGA)和聚(D,L-丙交酯)(PLA)微球。对微球的载药量、杂质含量和粒径进行了表征。此外,将微球在醋酸盐缓冲液(pH 4.0)和磷酸盐缓冲盐水(PBS)(pH 7.2)中进行体外释放试验。在醋酸盐缓冲液中,由低分子量PLGA 50:50、PLGA 85:15和PLA聚合物(≤10 kDa)组成的3批微球显示100%释放,杂质形成最少(<10%)。高分子量PLGA 50:50微球(28 kDa)在醋酸盐缓冲液中仅显示70%的累积释放,且有明显的杂质形成(约24%)。另一方面,在PBS(pH 7.4)中,相同的低分子量批次(PLGA 50:50、PLGA 85:15和PLA)仅观察到50%的释放,且疏水杂质形成百分比更高(即分别为40%、26%和10%)。此外,在PBS中,高分子量PLGA 50:50微球仅显示20%的药物释放,平均杂质含量约为66%。微球内化学修饰的肽杂质在经过提取程序后,通过傅里叶变换质谱(FT-MS)和液相色谱/质谱(LC-MS/MS)分析进行了结构确认。加合物化合物被鉴定为奥曲肽与聚合物微球内乳酸和乙醇酸单体的共价修饰共轭物。数据表明,由于空间位阻因素,与PLGA 50:50共聚物相比,丙交酯含量更高的聚合物更不易形成加合物杂质。